These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18080718)

  • 1. Prognosis of patients who relapse after fertility-sparing surgery in epithelial ovarian cancer.
    Marpeau O; Schilder J; Zafrani Y; Uzan C; Gouy S; Lhommé C; Morice P
    Ann Surg Oncol; 2008 Feb; 15(2):478-83. PubMed ID: 18080718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2008 Sep; 110(3):345-53. PubMed ID: 18586310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
    Suh-Burgmann E
    Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d'Oncologie Gynécologique).
    Morice P; Leblanc E; Rey A; Baron M; Querleu D; Blanchot J; Duvillard P; Lhommé C; Castaigne D; Classe JM; Bonnier P;
    Hum Reprod; 2005 May; 20(5):1379-85. PubMed ID: 15817592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery.
    Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2009 Apr; 113(1):75-82. PubMed ID: 19171373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
    Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
    J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse and survival in early-stage ovarian cancer.
    Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
    Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up results of fertility sparing surgery in patients with epithelial ovarian cancer.
    Anchezar JP; Sardi J; Soderini A
    J Surg Oncol; 2009 Jul; 100(1):55-8. PubMed ID: 19402079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
    Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).
    Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY
    Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort.
    Lenhard MS; Mitterer S; Kümper C; Stieber P; Mayr D; Ditsch N; Friese K; Burges A
    Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):189-94. PubMed ID: 19477060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
    Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
    Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis.
    Harter P; Hahmann M; Lueck HJ; Poelcher M; Wimberger P; Ortmann O; Canzler U; Richter B; Wagner U; Hasenburg A; Burges A; Loibl S; Meier W; Huober J; Fink D; Schroeder W; Muenstedt K; Schmalfeldt B; Emons G; du Bois A
    Ann Surg Oncol; 2009 May; 16(5):1324-30. PubMed ID: 19225844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivisceral cytoreductive surgery in FIGO stages IIIC and IV epithelial ovarian cancer: results and 5-year follow-up.
    Scholz HS; Tasdemir H; Hunlich T; Turnwald W; Both A; Egger H
    Gynecol Oncol; 2007 Sep; 106(3):591-5. PubMed ID: 17619055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer.
    Borgfeldt C; Iosif C; Måsbäck A
    Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):110-4. PubMed ID: 16859821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcome and recurrence after conservative laparoscopic surgery for borderline ovarian tumors.
    Tinelli FG; Tinelli R; La Grotta F; Tinelli A; Cicinelli E; Schönauer MM
    Acta Obstet Gynecol Scand; 2007; 86(1):81-7. PubMed ID: 17230294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic and reproductive outcomes in patients with advanced-stage borderline ovarian tumors.
    Song T; Choi CH; Kim HJ; Lee W; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):204-8. PubMed ID: 21306816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term results of organ preserving therapy in ovarian carcinoma].
    Meier W; Korell M; Burges A; Hepp H
    Zentralbl Gynakol; 1996; 118(10):545-8. PubMed ID: 8999706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors?
    Cho YH; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
    Gynecol Oncol; 2006 Dec; 103(3):878-82. PubMed ID: 16859736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
    Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
    Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.